IRWD 8-K 2026-11-05

IRONWOOD PHARMACEUTICALS INC (IRWD) 8-K dated 2026-11-05 — accession 0001104659-26-123029.

IRONWOOD PHARMACEUTICALS INC (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.

IRONWOOD PHARMACEUTICALS INC filed a 8-K on 2026-11-05. Accession 0001104659-26-123029.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IRWD revenue for 2025-12-31 was $296.2M. Net income was $24.0M. Revenue was down 15.7% from 2024-12-31 to 2025-12-31. IRWD currently screens at market cap $579.4M.

Not investment advice. The IRWD SEC hub lists recent forms. The stock page is the research view.